Skip to main content
. 2018 Sep 9;49(4):463–471. doi: 10.1111/ejn.14109

Figure 3.

Figure 3

Schematic representation reflecting the struggle of developing safe and efficient protocols that prevent the reprogrammed cell product to revert back to its original state. An additional concern with autologous therapy is to exclude the expression of disease‐related pathology in the converted neuron